Aiforia Technologies

Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.

Founded 2013 Finland

Finland 81 employees IPO Total: $65.00M AI, Biotechnology +5

General Information

Company Name Aiforia Technologies

Founded Year 2013

Location

Finland

Employees 81

Industries AI, Biotechnology, Education +4

Funding Stage IPO

Business Model B2B, SaaS, Platform

Revenue Model Subscription, Tiered Pricing, Usage Based

Offices as of Oct 2026

Helsinki, Finland Cambridge, United States Paris, France

Social

BounceWatch is an independent company data service, not affiliated with Aiforia Technologies. To contact Aiforia Technologies, visit aiforia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aiforia Technologies compare?

A PDF of Aiforia Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aiforia Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 16, 2026

Aiforia Technologies participated in a masterclass in Bologna, where they demonstrated their Breast Cancer HER2 model for AI-supported diagnosis.

Feature Release Oct 15, 2026

The upgraded and redesigned Aiforia® Create version 8.0 sets a new benchmark in digital pathology, enabling users to build high-precision deep learning AI models without code.

New Partnership Oct 08, 2026

Aiforia Technologies announced a new collaboration with PathAI to make Aiforia's AI solutions available via PathAI's AISight® Marketplace.

Major Customer Win Oct 06, 2026

Aiforia Technologies recognized Unilabs for their contribution leading the strategic national rollout of digital pathology and artificial intelligence across Unilabs’ Swiss network.

Actively Hiring Sep 22, 2026

Hiring for 2 positions in the last 30 days.

Get alerts when Aiforia Technologies shows new signals

About Aiforia Technologies

Aiforia Technologies, founded in 2013, is a cutting-edge company headquartered in Finland. Specializing in deep learning AI for image analysis, they provide advanced software solutions that leverage artificial intelligence to enhance the efficiency and precision of medical image analysis across various disciplines, including oncology and neuroscience.

The company's slogan, "Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis," encapsulates its mission to empower pathologists and researchers. Aiforia aids in the detection of disease biomarkers, accelerates drug development, and refines cancer diagnostics, effectively transforming healthcare from discovery to diagnosis.

In June 2021, Aiforia secured a €12.60M Series B investment led by PHC Holdings. Their focus on AI-driven innovation places them at the forefront of the convergence of biotechnology and healthcare, appealing to investors seeking opportunities in this rapidly evolving space.

Business keywords: Deep Learning AI, Image Analysis, Digital Pathology, Clinical Diagnostics, Oncology, Neuroscience, Biomarker Identification, R&D Acceleration, Cloud-based Computing, Medical Image Analysis, Virtual Microscopy, SaaS Solutions, Digital Image Management, Pathology Support

Services & Products

Clinical Solutions

Research Solutions

AI Development Tool

Veterinary Solutions

Target Customers

Pathologists Scientists in Clinical Labs Preclinical Researchers Academic Labs Veterinary Diagnostic Labs

Funding Rounds & Investors (10)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Post-IPO Equity	€20.00M	1	European Investment Bank	01 Jul 2026
Post-IPO Equity	€4.20M	-		01 Dec 2025
Post-IPO Equity	€8.00M	-		01 May 2025
IPO	Undisclosed	-		01 Dec 2021
Series B	€25.20M	3	Nordic Capital, Phc +1	01 Jun 2021
Series A	€5.00M	3	Ascend Capital Partners, ACME Investments +1	01 Dec 2017
Seed	€400.00K	1	Kaikarhenni Oy	01 Jan 2016
Seed	$1.50M	1	Business Finland	01 Oct 2015
Early VC	€700.00K	2	Mårten Mickos, Jukka Tapaninen	01 Jan 2015
Spinout	Undisclosed	1	University of Helsinki	01 Jan 2013

Latest News

View All

Aiforia Technologies PLC (STU:L6J) (H1 2026) Earnings Call Highlights: Strategic Expansion Amid ...

Yahoo Finance Aug 28, 2026

Aiforia Technologies Alternatives & Competitors

View All Alternatives

Aiforia Technologies vs

Virasoft Corporation United States

Connecting People. Elevating Patient Care. Complete Pathology Workflows with Integrated Digital Path...

43 employees

AI, Biotechnology

Compare Aiforia Technologies vs Virasoft Corporation

Aiforia Technologies vs

Tribun Health France

Bring to light more than the eye can see.

Grant

59 employees

AI, Health Care

Aiforia Technologies vs

Mindpeak Germany

Our mission is to enable personalised cancer treatment through AI tissue diagnostics

Series A

53 employees

AI, Biotechnology

Compare Aiforia Technologies vs Mindpeak

View all alternatives

FAQ About Aiforia Technologies

Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.

Aiforia Technologies was founded in 2013.

Aiforia Technologies is headquartered in Finland. As of Oct 2026, it also has offices in Helsinki, Finland, Cambridge, United States and Paris, France.

Aiforia Technologies operates in AI, Biotechnology, Education, Health Care, Information Technology, Life Sciences and Machine Learning. Its work centres on Deep Learning AI, Image Analysis, Digital Pathology and Clinical Diagnostics. Its customers include Pathologists, Scientists in Clinical Labs and Preclinical Researchers.

Aiforia Technologies has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Tiered Pricing and Usage Based.

Aiforia Technologies has approximately 81 employees.

Aiforia Technologies has completed 10 funding rounds, raising a total of $65.00M. The latest funding stage is IPO.

Aiforia Technologies offers: Clinical Solutions, Research Solutions, AI Development Tool, Veterinary Solutions.

Top alternatives and competitors to Aiforia Technologies include Virasoft Corporation, Tribun Health, Mindpeak, radiomics.bio, Paige. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Aiforia Technologies and Virasoft Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aiforia Technologies, https://bouncewatch.com/company/aiforia-technologies, updated 12 October 2026. When citing, please name BounceWatch and link this page.

Aiforia Technologies

General Information

Discover More

What changed at Aiforia Technologies recently?

About Aiforia Technologies

Services & Products

Target Customers

Funding Rounds & Investors (10)

Latest News

Aiforia Technologies Alternatives & Competitors

FAQ About Aiforia Technologies